Clinical Trials Directory

Trials / Completed

CompletedNCT02999789

Interventions To Help Asthma Clinical Adherence

Interventions to Help Asthma Clinical Adherence

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
5 Years – 17 Years
Healthy volunteers
Accepted

Summary

To conduct a pilot test to estimate the effect of a novel reminder system in improving daily asthma controller medication adherence rates in children with monolingual Spanish-speaking guardians who have limited English Proficiency (LEP).

Detailed description

The primary hypothesis is to conduct a pilot test to estimate the effect of the SmartInhaler device in improving daily asthma controller medication adherence rates in children with monolingual Spanish- speaking guardians who have LEP during a six-week intervention period when compared to baseline medication adherence rates in a preceding six-week run-in period. The secondary hypothesis is to determine whether the patient reminder system can improve asthma symptom control during the same six-week intervention period. The third hypothesis is to assess if there are specific, patient behavior characteristics which are associated with the success of a novel asthma medication reminder system.

Conditions

Interventions

TypeNameDescription
DEVICESmartInhaler with reminder function turned onThe SmartInhaler is a medication monitoring system that functions as a patient reminder device. It monitors asthma medication adherence and also functions by providing an audiovisual reminder.
DEVICESmartInhalerThe SmartInhaler is a medication monitoring system manufactured by Adherium that also functions as a patient reminder device. It monitors asthma medication adherence and also functions by providing an audiovisual reminder.

Timeline

Start date
2017-01-01
Primary completion
2019-11-01
Completion
2019-11-01
First posted
2016-12-21
Last updated
2023-04-18
Results posted
2023-04-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02999789. Inclusion in this directory is not an endorsement.